Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
BiomeMega runs a Biotechnology Research operation from Singapore. It is privately held, and its site is biomemega.com. It holds one address on record, all in Singapore. Headcount on record is 3. Its latest round on record is Pre seed, with no amount recorded.
BiomeMega is a cutting-edge Biotech startup that specialises in using deep tech (synbio, precision fermentation and bioengineering) to promote innovation for industry partners. Some of our applications include the obtaining of membrane-bound Omega 3, 7 & 9 as post-biotic ingredients for use in nutraceuticals, cellular cosmetics, and pharmaceuticals.
We aim to transform the probiotic industry with a focus on human health, which can also be applied to improve animal diets while boosting supply sustainability with Australian provenance, enhancing the function of products in market, preventing diseases, and leveraging our microbiome R&D breakthroughs through collaboration with outstanding academic partners.
Our expert team and partners are talented and passionate about what we do, and we envisage bringing to market a bank of sustainable ingredients, first-in-class pharmaceuticals, innovative nutraceuticals, and more outcomes that have started with the discovery and optimization of probiotics capable of producing Omega 7, Omega 9, and which contain both canonical and alternative Omega 3 pathways.
As advocates for the transformative power of both pre, pro and post-biotics combined with the super nutrients, Omegas and membrane fragments, the team at BiomeMega have been sharing our passion for crafting the new natural while developing formulations and envisaging personalized ingredients that will help Australia reach and sustain our best potential.
More exciting milestones to come.
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
| Rounds | 1 |
|---|---|
| Axis | 2022 to 2026 |
| Pre seed · 29 Nov 2024 | not disclosed |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
2 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
3 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
One address on record, Singapore only. Primary: Biopolis Drive, Singapore 138623.
One round. Latest 29 November 2024: pre seed, investor Big Idea Ventures, no amount recorded.
4 profiles list BiomeMega as a peer — 56th percentile in Biotechnology Research. It lists ten peers of its own.